You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2024

Litigation Details for Biogen International GmbH v. Banner Life Sciences LLC (D. Del. 2018)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in Biogen International GmbH v. Banner Life Sciences LLC
The small molecule drugs covered by the patents cited in this case are ⤷  Sign Up and ⤷  Sign Up .

Details for Biogen International GmbH v. Banner Life Sciences LLC (D. Del. 2018)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 External link to document
2018-12-26 1 Complaint against Banner for patent infringement of U.S. Patent Nos. 7,320,999 (“the ʼ999 patent”) and 8,399,514 …action for patent infringement of U.S. Patent No. 7,619,001 (“the ’001 patent”) (“asserted patent” or “patent-in-suit… to the ʼ999 and ʼ514 patents and U.S. Patent Nos. 6,509,376 (“the ʼ376 patent”) and 8,759,393. …) as to the ʼ376, ʼ999, ʼ001 and ʼ514 patents and U.S. Patent No. 7,803,840. {01400147;v1 } … FIRST COUNT FOR PATENT INFRINGEMENT (’001 PATENT) 19. Biogen realleges External link to document
2020-01-06 52 Memorandum Opinion s U.S. Patent No. 7,619,001 ("the ' 001 Patent"), which is subject to a patent term extension…holders of patents on approved patented products with an extended term of protection under the patent to compensate… ('001 Patent, els. 1, 5) Of the compounds listed in the ' 001 Patent' s claims…restoration period of the patent does not extend to all products protected by the patent but only to the product…x27;001 Patent originally set to expire on April 1, 2018, Biogen sought and received a patent term extension External link to document
2020-01-12 55 Exhibit A-C infringement regarding all claims of U.S. Patent No. 7,619,001 for the reasons stated in the Court Memorandum…Plaintiff’s claims of infringement of U.S. Patent No. 7,619,001 and as to Defendant’s counterclaims for …declaratory judgment of noninfringement of U.S. Patent No. 7,619,001; 3. Any motion for an award of costs…infringement regarding all asserted claims of U.S. Patent No. 7,619,001 for the reasons stated in the Court Memorandum…Plaintiff’s claims of infringement of U.S. Patent No. 7,619,001 and as to Defendant’s counterclaims for External link to document
2020-01-19 59 Exhibit 1-3 Specifically, the Court found U.S. Patent No. 6,598,603 invalid and U.S. Patent Number 7,524,834 not infringed…claim of infringement regarding all claims of U.S. Patent No. 7,619,001 for the reasons stated in the Court… to Plaintiff’s claims of infringement of U.S. Patent No. 7,619,001 and as to Defendant’s counterclaims…declaratory judgment of noninfringement of U.S. Patent No. 7,619,001. 3. Any motion for… UNITED STATES DISTRICT JUDGE: In this patent infringement action, the Court issued an Opinion External link to document
2020-01-20 61 Proposed Order infringement regarding all claims of U.S. Patent No. 7,619,001 for the reasons stated in the Court’s Memorandum…Plaintiff’s claims of infringement of U.S. Patent No. 7,619,001 and as to Defendant’s counterclaims for …declaratory judgment of noninfringement of U.S. Patent No. 7,619,001. {01528574;v1 } Case 1:18-cv-02054-LPS…2018 23 January 2020 1:18-cv-02054 835 Patent - Abbreviated New Drug Application(ANDA) None External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.